Valisure, a New Haven, CT-based healthcare company focused on independent quality assurance in pharmaceutical drugs, received an investment from AlleyCorp.
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate its research and development efforts, expand its team of experts, and further strengthen its position as a market leader in the independent pharmaceutical quality assurance space.
Led by new CEO Chip Phillips, Valisure is a healthcare supply chain technology company whose mission is to provide transparency to quality and independent certification through chemical analysis. The services are being adopted by major public and private health systems.
Chip Phillips is an accomplished healthcare executive with a focus on the pharmacy service space. He brings a wealth of experience, having served as President of ANDA, a subsidiary of Teva Pharmaceutical Industries, and was an executive leader at CVS Health. At CVS, he spent time leading the Medicaid business, TheraCom, Inc., and Minute Clinic.
With Chip’s appointment as CEO, Valisure’s Co-Founder David Light assumed the role of President.
Likewise, Wolfgang Hinz, Ph.D., has assumed a leadership position as the Chief Scientific Officer, Adam Clark-Joseph, Ph.D., as Chief Analytics Officer, and Jill Nailor, R.Ph., has advanced to the position of Chief Business Development Officer.
FinSMEs
28/02/2024